VECTOR – Trademark Portfolio

Entity Type: 02

VECTOR holds 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 17 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 11 trademarks are registered. Notable registered marks include M.O.M., BLOXALL, IMMEDGE, IMMPACT, and IMMPRESS. The owner is based in Riverside, CA.

8012 La Crosse Way

Riverside, CA 92508

20 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

VECTOR's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (17 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

25
Clothing (2 filings)

Clothing, footwear, headgear

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does VECTOR have?

VECTOR has 20 U.S. trademarks filed with the USPTO. Of these, 11 registered, 5 abandoned, 4 cancelled.

What trademark classes does VECTOR file in?

VECTOR files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 25 (Clothing), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are VECTOR's most well-known trademarks?

VECTOR's registered trademark portfolio includes well-known marks such as M.O.M., BLOXALL, IMMEDGE, IMMPACT, and IMMPRESS. These are among 11 currently registered trademarks in the portfolio.

What is VECTOR's trademark registration success rate?

VECTOR has a 55% trademark registration rate, with 11 out of 20 resolved applications resulting in successful registration. Currently, 0 applications are pending review.